A novel anthracycline antibiotic designated rudolphomycin is produced by fermentaion of Actinosporangium sp. ATCC 31127 and isolation of the new antibiotic free of substances co-produced therewith. Rudolphomycin and its pharmaceutically acceptable salts exhibit antimicrobial activity and inhibit the growth of mammalian tumors.
一种新的
蒽环类抗生素,名为Rudolphomycin,是通过Actinosporangium sp. A
TCC 31127的发酵生产,并分离出与其共同生产的物质。 Rudolphomycin及其药物可接受的盐具有抗微
生物活性并抑制哺乳动物肿瘤的生长。